|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1505 EUR | 0.00% |
|
-16.39% | -55.34% |
| 05-14 | Aeffe postpones approval of FY results to June 30 | RE |
| 05-13 | Aeffe shares up 0.7% after Oxy Capital makes preliminary restructuring bid | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -2.57 | 1.58 | 1.08 | -2.8 | -4.69 | |||||
Return on Total Capital | -3.47 | 2.15 | 1.49 | -3.79 | -6.51 | |||||
Return On Equity % | -12.2 | 8.11 | -7.88 | -33.84 | 21.94 | |||||
Return on Common Equity | -13.39 | 9.04 | -7.87 | -34.03 | 21.85 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 5.81 | 36.07 | 17.54 | 9.49 | 6.15 | |||||
SG&A Margin | 2.17 | 24.35 | 5.97 | 5.86 | 5.71 | |||||
EBITDA Margin % | -3.87 | 6.18 | 4.78 | -3.57 | 1.48 | |||||
EBITA Margin % | -5.69 | 4.74 | 3.41 | -5.24 | -10.3 | |||||
EBIT Margin % | -7.29 | 3.53 | 2.25 | -6.54 | -11.84 | |||||
Income From Continuing Operations Margin % | -8.35 | 3.64 | -2.49 | -9.71 | 7.16 | |||||
Net Income Margin % | -7.65 | 3.64 | -2.49 | -9.76 | 7.11 | |||||
Net Avail. For Common Margin % | -7.65 | 3.64 | -2.49 | -9.76 | 7.11 | |||||
Normalized Net Income Margin | -4.99 | 1.42 | -0.11 | -6.78 | -10.42 | |||||
Levered Free Cash Flow Margin | 6.23 | 13.11 | -1.36 | 3.08 | 12.26 | |||||
Unlevered Free Cash Flow Margin | 6.84 | 13.58 | -0.63 | 4.93 | 14.84 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.56 | 0.71 | 0.77 | 0.68 | 0.63 | |||||
Fixed Assets Turnover | 1.67 | 2.17 | 2.3 | 1.97 | 1.83 | |||||
Receivables Turnover (Average Receivables) | 6.68 | 7.28 | 6.24 | 5.36 | 5.18 | |||||
Inventory Turnover (Average Inventory) | 2.38 | 2.12 | 2.88 | 2.6 | 2.53 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.39 | 1.43 | 1.2 | 1.08 | 1.42 | |||||
Quick Ratio | 0.72 | 0.82 | 0.63 | 0.53 | 0.72 | |||||
Operating Cash Flow to Current Liabilities | 0.06 | 0.32 | -0.01 | 0.03 | 0.14 | |||||
Days Sales Outstanding (Average Receivables) | 54.82 | 50.11 | 58.53 | 68.14 | 70.63 | |||||
Days Outstanding Inventory (Average Inventory) | 153.79 | 171.97 | 126.68 | 140.18 | 144.45 | |||||
Average Days Payable Outstanding | 100.86 | 138.46 | 97.09 | 107.43 | 115.26 | |||||
Cash Conversion Cycle (Average Days) | 107.76 | 83.62 | 88.12 | 100.89 | 99.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 102.65 | 168.91 | 230.85 | 338.34 | 176.49 | |||||
Total Debt / Total Capital | 50.65 | 62.81 | 69.77 | 77.19 | 63.83 | |||||
LT Debt/Equity | 61.3 | 127.37 | 145.05 | 204.18 | 124.96 | |||||
Long-Term Debt / Total Capital | 30.25 | 47.37 | 43.84 | 46.58 | 45.2 | |||||
Total Liabilities / Total Assets | 63.41 | 73.01 | 78.01 | 82.93 | 75.07 | |||||
EBIT / Interest Expense | -7.53 | 4.67 | 1.93 | -2.21 | -2.87 | |||||
EBITDA / Interest Expense | 2.25 | 14.6 | 9.39 | 0.96 | 2.3 | |||||
(EBITDA - Capex) / Interest Expense | 0.58 | 13.84 | 7.63 | 0.48 | 2.1 | |||||
Total Debt / EBITDA | 30.17 | 5.52 | 6.36 | 28.71 | 6.71 | |||||
Net Debt / EBITDA | 23.62 | 4.67 | 5.81 | 27.15 | 5.9 | |||||
Total Debt / (EBITDA - Capex) | 116.23 | 5.82 | 7.82 | 57.73 | 7.34 | |||||
Net Debt / (EBITDA - Capex) | 91 | 4.92 | 7.15 | 54.58 | 6.46 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -22.65 | 19.14 | 9.14 | -9.41 | -17.42 | |||||
Gross Profit, 1 Yr. Growth % | -74.73 | 31.9 | 10.36 | -50.95 | -46.5 | |||||
EBITDA, 1 Yr. Growth % | -129.03 | -312.2 | -15.59 | -167.62 | -134.15 | |||||
EBITA, 1 Yr. Growth % | -149.87 | -206.57 | -21.42 | -239.18 | 62.25 | |||||
EBIT, 1 Yr. Growth % | -174.83 | -161.01 | -30.43 | -363.22 | 49.49 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -294.57 | -151.92 | -174.68 | 253.25 | -160.84 | |||||
Net Income, 1 Yr. Growth % | -282.99 | -156.67 | -174.58 | 255.42 | -160.13 | |||||
Normalized Net Income, 1 Yr. Growth % | -198.37 | -135.59 | -108.79 | 5.28K | 26.85 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -285.12 | -156.85 | -175.62 | 255.43 | -159.94 | |||||
Accounts Receivable, 1 Yr. Growth % | -5.85 | 27.98 | 25.62 | -10.71 | -27.52 | |||||
Inventory, 1 Yr. Growth % | -2.47 | -16.36 | 27.68 | -3.82 | -20.5 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.57 | -10.73 | 18.71 | -5.33 | -17.04 | |||||
Total Assets, 1 Yr. Growth % | -3.17 | -8.89 | 12.16 | -7.04 | -15.19 | |||||
Tangible Book Value, 1 Yr. Growth % | -20.52 | -32.28 | -14.62 | -63.04 | 200.77 | |||||
Common Equity, 1 Yr. Growth % | -13.51 | -18.94 | -8.61 | -27.97 | 23.64 | |||||
Cash From Operations, 1 Yr. Growth % | -46.64 | 373.89 | -103.17 | -517 | 193.11 | |||||
Capital Expenditures, 1 Yr. Growth % | -42.6 | -57.22 | 287.39 | -37.13 | -52.91 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 56.86 | 141.11 | -111.3 | -305.62 | 228.38 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 47.79 | 128.45 | -105.04 | -811.55 | 148.52 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -10.88 | -4 | 14.03 | -0.56 | -13.51 | |||||
Gross Profit, 2 Yr. CAGR % | -52.12 | 36.77 | -16.34 | -26.43 | -48.77 | |||||
EBITDA, 2 Yr. CAGR % | -51.05 | -25.62 | 33.84 | -24.45 | -51.95 | |||||
EBITA, 2 Yr. CAGR % | -36.78 | -29.67 | -8.49 | 4.58 | 50.27 | |||||
EBIT, 2 Yr. CAGR % | -21.81 | -34.28 | -34.85 | 35.33 | 98.37 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 16.54 | 0.5 | -37.73 | 62.42 | 46.6 | |||||
Net Income, 2 Yr. CAGR % | 13.1 | 1.84 | -34.99 | 62.81 | 46.19 | |||||
Normalized Net Income, 2 Yr. CAGR % | -14.44 | -42.3 | -82.31 | 117.46 | 726.07 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 13.95 | 2.59 | -34.43 | 63.94 | 45.96 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.8 | 9.77 | 26.79 | 5.91 | -19.55 | |||||
Inventory, 2 Yr. CAGR % | 2.38 | -9.68 | 3.34 | 10.82 | -12.56 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 63.97 | -8.68 | 2.94 | 6.01 | -11.38 | |||||
Total Assets, 2 Yr. CAGR % | 9.99 | -6.07 | 1.09 | 2.11 | -11.21 | |||||
Tangible Book Value, 2 Yr. CAGR % | 11 | -26.64 | -23.96 | -43.83 | 5.43 | |||||
Common Equity, 2 Yr. CAGR % | -5.1 | -16.27 | -13.93 | -18.87 | -5.63 | |||||
Cash From Operations, 2 Yr. CAGR % | -36.58 | 59.02 | -61.26 | -63.66 | 249.61 | |||||
Capital Expenditures, 2 Yr. CAGR % | -17.75 | -50.44 | 28.74 | 56.06 | -45.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -6.24 | 98.28 | -47.8 | -51.79 | 159.85 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -2.89 | 87.02 | -66.06 | -40.09 | 320.52 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -4.04 | -1.82 | 0.19 | 5.61 | -6.54 | |||||
Gross Profit, 3 Yr. CAGR % | -36.26 | 19.27 | -0.24 | -29.98 | -33.84 | |||||
EBITDA, 3 Yr. CAGR % | -34.34 | -22.99 | -22.41 | 6.6 | -42.02 | |||||
EBITA, 3 Yr. CAGR % | -21.72 | -26.54 | -27.02 | 5.24 | 21.07 | |||||
EBIT, 3 Yr. CAGR % | -8.51 | -29.33 | -33.02 | 3.77 | 39.89 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 26.63 | -11 | -8.97 | 11.05 | 17.08 | |||||
Net Income, 3 Yr. CAGR % | 23.03 | -10.17 | -8.21 | 14.53 | 16.81 | |||||
Normalized Net Income, 3 Yr. CAGR % | 1.62 | -37.2 | -69.18 | 18.95 | 81.7 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 23.72 | -9.62 | -7.33 | 15.18 | 17.23 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.41 | 5.07 | 14.82 | 12.81 | -6.67 | |||||
Inventory, 3 Yr. CAGR % | 3.76 | -4.29 | 1.37 | 0.9 | -0.8 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 39.98 | 33.89 | -0.33 | 0.11 | -2.31 | |||||
Total Assets, 3 Yr. CAGR % | 8.15 | 3.3 | -0.35 | -1.7 | -4.02 | |||||
Tangible Book Value, 3 Yr. CAGR % | 27.6 | -5.86 | -22.83 | -40.22 | -1.73 | |||||
Common Equity, 3 Yr. CAGR % | 0.48 | -9.96 | -13.79 | -18.89 | -6.64 | |||||
Cash From Operations, 3 Yr. CAGR % | -15.86 | 23.99 | -56.9 | -14.46 | -27.12 | |||||
Capital Expenditures, 3 Yr. CAGR % | 18.13 | -33.85 | -1.65 | 1.38 | 4.67 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 3.69 | 30.12 | -23.69 | -17.56 | -8.61 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 5.11 | 30.68 | -43.92 | -6.41 | -3.74 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.49 | 3.05 | 2.82 | -1.32 | -5.53 | |||||
Gross Profit, 5 Yr. CAGR % | -21.91 | 14.12 | 0.34 | -15.08 | -23.59 | |||||
EBITDA, 5 Yr. CAGR % | -12.32 | -4.9 | -14.55 | -23.58 | -35.94 | |||||
EBITA, 5 Yr. CAGR % | 0.72 | -5.85 | -17.86 | -15.39 | -2.57 | |||||
EBIT, 5 Yr. CAGR % | 19.99 | -4.13 | -21.01 | -8.36 | 3.41 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 68.71 | 22.61 | -4.67 | 13.22 | 10.15 | |||||
Net Income, 5 Yr. CAGR % | 69.66 | 27.2 | -4.68 | 13.96 | 10.57 | |||||
Normalized Net Income, 5 Yr. CAGR % | 52.17 | -5.47 | -50.01 | 3.21 | 14.83 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 70.17 | 27.66 | -4.03 | 14.69 | 11.14 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.43 | 4.21 | 8.36 | 5.4 | -0.41 | |||||
Inventory, 5 Yr. CAGR % | 3.96 | 0.45 | 3.59 | 1.49 | -4.45 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 20.71 | 18.72 | 23.79 | 21.95 | -4.91 | |||||
Total Assets, 5 Yr. CAGR % | 5.29 | 3.53 | 5.27 | 2.82 | -4.85 | |||||
Tangible Book Value, 5 Yr. CAGR % | 53.38 | 19.97 | 3.74 | -23.43 | -12.57 | |||||
Common Equity, 5 Yr. CAGR % | 2.39 | -2.41 | -5.55 | -13.63 | -10.61 | |||||
Cash From Operations, 5 Yr. CAGR % | -4.26 | 35.32 | -38.3 | -24.11 | -0.43 | |||||
Capital Expenditures, 5 Yr. CAGR % | -2.04 | -10.01 | 22.27 | -6.75 | -22.39 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 18.3 | 10.87 | -20.59 | -12.53 | 24.58 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.52 | 10.48 | -32.65 | -4.34 | 25.55 |
- Stock Market
- Equities
- AEF Stock
- Financials Aeffe S.p.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















